4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002023658-25-000085
Chief Legal Officer sold 15,829 shares at $10.43 ($165,096)
- Chief Legal Officer acquired 15,829 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara Chief Legal Officer | 2025-06-16 | Option exercise 10b5-1 | +15,829 | $5.45 | $86,268 | 15,829 | D: show line 1 in the form |
| Meisner Lara Chief Legal Officer | 2025-06-16 | Sale 10b5-1 | −15,829 | $10.43 | $165,096 | 0 | D: show line 2 in the form |
| Open-market sales · 15,829 sh · avg $10.43 · $165,096 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara Chief Legal Officer | 2025-06-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,085 | 60,854 | D: show line 3 in the form | ||
| Meisner Lara Chief Legal Officer | 2025-06-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,744 | 97,443 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1750281133.xml…